Patent · US Active

Method of removing antibody free light chains from blood

US7875183B2 · kind B2 · utility

15Cited by

0References

17Claims

0Family size

Assignees

GAMBRO LUNDIA AB · SE
THE BINDING SITE GROUP LIMITED · GB

Inventors

Arthur R. Bradwell · Birmingham, GB
Hermann Goehl · Bisingen, DE
Markus Storr · Echterdingen, DE

Key dates

Filing date	Nov 15, 2006
Grant date	Jan 25, 2011
Priority date	—
Expiry date	Jun 2, 2027

Classification

Technology area (CPC B)Performing Operations; Transporting
CPC primaryB01D2325/02833
WIPO fieldChemical engineering
WIPO sectorChemistry

Abstract

There is provided a method of reducing blood free light chain concentration in a subject, the method comprising the step of subjecting the subject's blood to haemodialysis, haemodiafiltration or haemofiltration. There is also provided the use of a dialysis membrane which is a membrane that allows passage of molecules having a molecular weight of up to 45 kDa in presence of whole blood, and has a molecular weight exclusion limit in water of about 200 kDa in the preparation of a haemodialysis unit for conducting haemodialysis, haemodiafiltration or haemofiltration on a subject to reduce blood free light chain concentration in the patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.